Cardiotoxicity is a feared side effect that may limit the clinical use of anthracyclines. It may
indeed affect the quality of life and survival of patients with cancer, regardless of oncological …

Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet many
people perceive breast cancer to be the number one threat to women's health. CVD and …

Dirofilariasis represents a zoonotic mosaic, which includes two main filarial species
(Dirofilaria immitis and D. repens) that have adapted to canine, feline, and human hosts with …

Background Cardiac injury is now a common complication of coronavirus disease (COVID-
19), but it remains unclear whether cardiac injury-related biomarkers can be independent …

Cardiac troponins are sensitive and specific markers of myocardial injury. The troponin
concentration can be thought of as a quantitative measure of the degree of injury sustained …

Defining the chronic cardiotoxic effects of drugs during preclinical screening is hindered by
the relatively short lifetime of functional cardiac tissues in vitro, which are traditionally …

Cardiovascular toxicity remains a major cause of concern during preclinical and clinical
development as well as contributing to post-approval withdrawal of medicines. This issue is …

10+ Years of Updates Since First EditionNewcomers to the animal clinical chemistry and
toxicology fields quickly find that the same rules of human medicine do not always apply …

Chemotherapy-induced cardiotoxicity remains an unresolved problem strongly impacting
the quality of life and the overall survival of cancer patients. The main strategy for minimizing …

Drug-induced cardiotoxicity is emerging as an important issue among cancer survivors. For
several decades, this topic was almost exclusively associated with anthracyclines, for which …